Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells
The FASEB Journal · 2024
DOI: 10.1096/fj.202400346r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Nour Abou Nader und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Reproduction et Fertilité, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada. Hauptthemen laut MEDLINE: Sertoli Cells, Protein Serine-Threonine Kinases, YAP-Signaling Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC), Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Recent reports suggest that the Hippo signaling pathway regulates testis development, though its exact roles in Sertoli cell differentiation remain unknown. Here, we examined the functions of the main Hippo pathway kinases, large tumor suppressor homolog kinases 1 and 2 ( Lats1 and Lats2 ) in developing mouse Sertoli cells. Conditional inactivation of Lats1/2 in Sertoli cells resulted in the disorganization and overgrowth of the testis cords, the induction of a testicular inflammatory response and germ cell apoptosis. Stimulated by retinoic acid 8 (STRA8) expression in germ cells additionally suggested that germ cells may have been preparing to enter meiosis prior to their loss. Gene expression analyses of the developing testes of conditional knockout animals further suggested impaired Sertoli cell differentiation, epithelial‐to‐mesenchymal transition, and the induction of a specific set of genes associated with Yes‐associated protein (YAP) and transcriptional coactivator with PDZ‐binding motif (TAZ)‐mediated integrin signaling. Finally, the involvement of YAP/TAZ in Sertoli cell differentiation was confirmed by concomitantly inactivating Yap/Taz in Lats1/2 conditional knockout model, which resulted in a partial rescue of the testicular phenotypic changes. Taken together, these results identify Hippo signaling as a crucial pathway for Sertoli cell development and provide novel insight into Sertoli cell fate maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche en Reproduction et Fertilité, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
- Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, Massachusetts, USA.
- École Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
ORCID-Profile: Nour Abou Nader, Guillaume St-Jean, Gustavo Zamberlam, Julie Brind'Amour, David Pépin, Alexandre Boyer
Förderung
- Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Abou Nader, N., Charrier, L., Meisnsohn, M. C., Banville, L., Deffrennes, B., St-Jean, G., Boerboom, D., Zamberlam, G., Brind'Amour, J., Pépin, D., & Boyer, A. (2024). Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells. The FASEB Journal. https://doi.org/10.1096/fj.202400346r
Vancouver
Abou Nader N, Charrier L, Meisnsohn MC, Banville L, Deffrennes B, St-Jean G, et al. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells. The FASEB Journal. 2024. doi:10.1096/fj.202400346r
BibTeX
@article{AbouNader2024,
author = {Abou Nader, Nour and Charrier, Laureline and Meisnsohn, Marie-Charlotte and Banville, Laurence and Deffrennes, Bérengère and St-Jean, Guillaume and Boerboom, Derek and Zamberlam, Gustavo and Brind'Amour, Julie and Pépin, David and Boyer, Alexandre},
title = {Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202400346r}
}
EUVIMED